RENEE GLOVER

NAGS HEAD, NC NPI 1699779124

General Payments — all program years on this page

$1,765.93

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 57
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $700.46 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $700.4616

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $512.0910
Amgen Inc. $118.742
Galderma Laboratories, L.P. $34.202
MERZ NORTH AMERICA, INC. $26.081
Biofrontera Inc. $9.351

By program year

Program yearAmountRecords
2018 $33.122
2019 $93.224
2020 $16.741
2021 $242.368
2022 $410.3515
2023 $269.6811
2024 $700.4616

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1092759497 Biofrontera Inc. $9.35 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103805366 ABBVIE INC. $23.29 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103805368 ABBVIE INC. $23.29 03/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103805370 ABBVIE INC. $18.31 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103805372 ABBVIE INC. $124.09 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103805374 ABBVIE INC. $18.50 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103805376 ABBVIE INC. $20.06 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103805378 ABBVIE INC. $121.36 08/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103805380 ABBVIE INC. $25.31 08/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103805382 ABBVIE INC. $108.45 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103805384 ABBVIE INC. $29.43 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117563424 Amgen Inc. $13.66 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117563426 Amgen Inc. $105.08 04/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145299806 Galderma Laboratories, L.P. $19.39 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145299808 Galderma Laboratories, L.P. $14.81 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146374292 MERZ NORTH AMERICA, INC. $26.08 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.